Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Biomarker Study in Men With Localized, Favorable, Intermediate-risk Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, interme…
Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)
Estimated
~$10 – $8,750
Candel Therapeutics, Inc.NCT07332000
Phase 2
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
This study is for adult men with previously untreated high risk, very high risk, or pelvic lymph node positive prostate cancer. The purpose of this study is to…
Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Estimated
~$10 – $6,250
Medical University of South CarolinaNCT07325721